TeenScreen – “Under Intense Criticism Nationally”
The Arkansas Democrat Gazette reports (below): "TeenScreen, developed by a Columbia University professor, has come under intense criticism nationally."
Bill Frist’s most Frequent Corporate Flight Hosts–Pharmaceutical companies
The nation’s most powerful legislators have grown accustomed to riding in plush private coporate jets. How does that affect public policy?
Marriage of Convenience: Mental Screening–Eli Lilly check $500k
Mental Screening ties to drug companies exposed. Screening for Mental Health (Harvard affiliated) received $500K from Eli Lillly. See: https://ahrp.org/children/mentalscreen/LillyCheck.jpg
TeenScreen hired high powered PR firms whose business is to create promotional campaigns to increase drug sales for its clients.
Safety of Newborn infants Threatened by Rx antidepressants during pregnancy
"During a hastily called press conference yesterday,” the FDA announced that it is considering ADDITIONAL warnings on the labels of SSRI drugs—Prozac, Paxil, Zoloft, et al.
Another Study Shows: Antipsychotic Trials Biased Towards Sponsor’s Drug
An independent review by a team of German analysts published in the American Journal of Psychiatry confirms that corporate bias is ubiquitous in clinical trials.
Polypharm & New Antipsychotics Not More Beneficial-Just More Expensive
"modern pharmacological treatment may be no more beneficial than older ones, despite their added cost."
Jane Pauley- from Steroids to mania to depression to Bi-Polar-to Drugs for Life
"After another four months or so on antidepressants, bringing me to a total of 10 months between the steroids and antidepressants, I was suddenly flipped into this hypomania."
FDA shielding Big Pharma
"Now they are terrified that their crimes of commission and omission could reap them the same whirlwind harvest of accountability."
Big Pharma: The Fool’s Gold that Heals_New Book
Big Pharma by Jacky Law reveals that in essence, most of the pharmaceutical industry’s claims are false; it is not the drug, but the placebo effect whose potency deserves almost all of the credit for any health improvement:
FDA Plan Would Aid Drug Makers in Liability Suits
FDA political appointees have embarked on a plan to divest the American consumer of the right to seek compensation for defective prescription drugs.
ACNP Task Force Ties to Pharma
Authors of the American College of Neuropsychopharmacology Task Force on SSRIs and Suicidal Behavior in Youth: their known ties to the pharmaceutical industry
FDA: NIMH SSRI Study Flawed–No Comparative Untreated Group
Even Dr. Robet Temple, FDA Medical Policy Director of the Center for Drug Evaluation & Research dismisses the claimed finidings of a flawed, but highly trumpeted recent SSRI study published in the American Journal of Psychiatry. The study was sponsored by the National Institute of Mental Health.